Abstract
Recent advances in cytometry instrumentation are enabling the generation of big at the single cell level for the identification of cell-based biomarkers, which will fundamentally change the current paradigm of diagnosis and personalized treatment of immune system disorders, cancers, and blood diseases. However, traditional flow cytometry (FCM) data analysis based on manual gating cannot effectively scale to address this new level of data generation. Computational data analysis methods have recently been developed to cope with the increasing data volume and dimensionality generated from FCM experiments. Making these computational methods easily accessible to clinicians and experimentalists is one of the biggest challenges that algorithm developers and bioinformaticians need to address. This paper describes FlowGate, a novel prototype cyberinfrastructure for web-based FCM data analysis, which integrates graphical user interfaces (GUI), workflow engines, and parallel computing resources for extensible and scalable FCM data analysis. The goal of FlowGate is to allow users to easily access state-of-the-art FCM computational methods developed using different programming languages and software on the same platform, when the implementations of these methods follow standardized I/O. By adopting existing data and information standards, FlowGate can also be integrated as the back-end data analytical platform with existing immunology and FCM databases. Experimental runs of two representative FCM data analytical methods in FlowGate on different cluster computers demonstrated that the task runtime can be reduced linearly with the number of compute cores used in the analysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.